Literature DB >> 22337848

Seroprevalence of hepatitis B: do blood donors represent the general population?

Hayat Kumbasar Karaosmanoglu1, Ozlem Altuntas Aydin, Semra Sandikci, Emine Rahsan Yamanlar, Ozcan Nazlican.   

Abstract

INTRODUCTION: In this study, we aimed to compare the HBV seroprevalances of voluntary blood donors and the healthy persons who required premarital screening.
METHODOLOGY: HBsAg ELISA results were collected retrospectively from the records of 9,949 blood donors and 954 healthy persons who required premarital screening.
RESULTS: HBsAg was detected in 182 of 9,949 (%1.8) voluntary blood donors and  32 of  954 (%3.4) healthy persons who required premarital screening. HBsAg seropositivity was significiantly higher in the healthy persons who required premarital screening than in blood donors (p = 0.0016).
CONCLUSION: Premarital screening is mandatory in our country, and it may provide more accurate epidemiological data to determine HBV seroprevalence than in other selected groups such as blood donors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22337848     DOI: 10.3855/jidc.2084

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  8 in total

1.  Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors.

Authors:  Diego M Flichman; Jorgelina L Blejer; Beatriz I Livellara; Viviana E Re; Sonia Bartoli; Juan A Bustos; Claudia P Ansola; Susana Hidalgo; Martin E Cerda; Alicia E Levin; Adriana Huenul; Victoria Riboldi; Elena M C Treviño; Horacio J Salamone; Felix A Nuñez; Robert J Fernández; Juan F Reybaud; Rodolfo H Campos
Journal:  BMC Infect Dis       Date:  2014-04-23       Impact factor: 3.090

Review 2.  Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.

Authors:  Jeffrey V Lazarus; Ida Sperle; Alexander Spina; Jürgen K Rockstroh
Journal:  Croat Med J       Date:  2016-10-31       Impact factor: 1.351

3.  Prevalence of Hepatitis B and C virus infection and their co-relation with hematological and hepatic parameters in subjects undergoing Premarital Screening in the Jazan Region, Kingdom of Saudi Arabia.

Authors:  Saleh Mohammed Abdullah
Journal:  Pak J Med Sci       Date:  2018 Mar-Apr       Impact factor: 1.088

4.  Viral hepatitis and Treponema pallidum prevalence in persons who underwent premarital blood tests in Argentina.

Authors:  Patricia Angeleri; Valeria Levite; Gabriela Vidiella; Joaquín Solari; Emma Coronel; Dan Adaszko; Ariel Adaszko; Cecilia Moyano; Diosnel Bouchet; Héctor Cuello; Viviana Molfese; Rosario Skarzauskas; Marcelo Vila; Carlos Falistocco; Maria A Pando
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

5.  Seroprevalence of hepatitis B and C viral infections in the premarital adult population of Al Majmaah, Saudi Arabia.

Authors:  Shabir Ahmad Mir; Bader Alshehri
Journal:  Malawi Med J       Date:  2021-09       Impact factor: 0.875

6.  Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.

Authors:  Warda Baha; Abderrahim Foullous; Noureddine Dersi; Thierry Paluku They-they; Khadija El alaoui; Nadia Nourichafi; Bouchra Oukkache; Fatiha Lazar; Soumaya Benjelloun; My Mustapha Ennaji; Abdelouhad Elmalki; Hassan Mifdal; Abdelouaheb Bennani
Journal:  BMC Public Health       Date:  2013-01-18       Impact factor: 3.295

7.  Hepatitis B, Hepatitis C and HIV seroprevalence in critically ill emergency medicine department patients in a tertiary inner city hospital in Istanbul, Turkey.

Authors:  Tuba Cimilli Ozturk; Ozlem Guneysel; Adem Tali; Sonay Ezgi Yildirim; Ozge Ecmel Onur; Serpil Yaylaci
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

8.  Fine-scale geographic clustering pattern of human T-cell leukemia virus type 1 infection among blood donors in Kyushu-Okinawa, Japan.

Authors:  Yasuko Sagara; Masako Iwanaga; Maiko Morita; Yasuhiro Sagara; Hitomi Nakamura; Hideaki Hirayama; Kazuo Irita
Journal:  J Med Virol       Date:  2018-07-10       Impact factor: 2.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.